Wray Jo, Hallas Claire N, Banner Nicholas R
Department of Cardiology, Harefield Hospital, Royal Brompton and Harefield NHS Trust, Harefield, Middlesex, UK.
Clin Transplant. 2007 Sep-Oct;21(5):622-7. doi: 10.1111/j.1399-0012.2007.00698.x.
Left ventricular assist devices (LVAD) are increasingly being used to treat patients in end-stage heart failure to facilitate survival to cardiac transplant or as a bridge to myocardial recovery. The technical innovation of the LVAD has a significant benefit on the patients' physical functioning. However, within the United Kingdom, there has been no systematic evaluation of the psychological adjustment and quality of life (QoL) of patients currently living with an LVAD, or of the differences in QoL for patients who are either explanted or transplanted.
To assess the differences in QoL and psychological adjustment for current LVAD patients, patients who have been transplanted from an LVAD and patients in whom the device has been explanted.
Twenty-two patients involved in an LVAD programme were recruited (18 men and four women; age range 18-60). Eight patients had an LVAD in situ, six patients had the LVAD explanted and eight had undergone transplantation. QoL and psychological functioning were assessed using previously validated measures.
Although there were no significant differences between the three groups, there was a trend for the LVAD patients to have higher levels of anxiety and depression and a lower QoL compared with transplanted or explanted patients.
For patients with an LVAD in situ, there was a trend for QoL and psychological functioning to be poorer than for transplanted and explanted patients. Larger studies will be needed to confirm these findings, but psychological assessment and interventions to reduce psychological morbidity and improve QoL will be important in these patients, particularly in view of the increasing numbers of LVADs being implanted and the possibility of their use for long-term "destination" therapy.
左心室辅助装置(LVAD)越来越多地用于治疗终末期心力衰竭患者,以促进其存活至心脏移植或作为心肌恢复的桥梁。LVAD的技术创新对患者的身体功能有显著益处。然而,在英国,目前尚未对现使用LVAD患者的心理调适和生活质量(QoL)进行系统评估,也未对装置已移除或已接受移植患者的生活质量差异进行评估。
评估当前LVAD患者、已接受LVAD移植患者和装置已移除患者在生活质量和心理调适方面的差异。
招募了22名参与LVAD项目的患者(18名男性和4名女性;年龄范围18 - 60岁)。8名患者仍保留LVAD,6名患者已移除LVAD,8名患者已接受移植。使用先前验证过的测量方法评估生活质量和心理功能。
尽管三组之间没有显著差异,但与移植或移除装置的患者相比,LVAD患者有焦虑和抑郁水平较高且生活质量较低的趋势。
对于仍保留LVAD的患者,其生活质量和心理功能有比移植和移除装置患者更差的趋势。需要更大规模的研究来证实这些发现,但心理评估和干预以降低心理发病率和改善生活质量对这些患者很重要,特别是鉴于植入LVAD的数量不断增加以及其用于长期“终点”治疗的可能性。